World J Mens Health.  2018 Jan;36(1):22-40. 10.5534/wjmh.17051.

Delayed Ejaculation: Pathophysiology, Diagnosis, and Treatment

Affiliations
  • 1Division of Andrology, Mansoura Faculty of Medicine, Mansoura, Egypt. ibrahamid2007@yahoo.com
  • 2Faculty of Medicine and Surgery, 6th October University, 6th October City, Egypt.

Abstract

Delayed ejaculation (DE) is a poorly defined and uncommon form of male sexual dysfunction, characterized by a marked delay in ejaculation or an inability to achieve ejaculation. It is often quite concerning to patients and their partners, and sometimes frustrates couples' attempts to conceive. This article aims to review the pathophysiology of DE and anejaculation (AE), to explore our current understanding of the diagnosis, and to present the treatment options for this condition. Electronic databases were searched from 1966 to October 2017, including PubMed (MEDLINE) and Embase. We combined "delayed ejaculation,""retarded ejaculation,""inhibited ejaculation," or "anejaculation" as Medical Subject Headings (MeSH) terms or keywords with "epidemiology,""etiology,""pathophysiology,""clinical assessment,""diagnosis," or "treatment." Relevant sexual medicine textbooks were searched as well. The literature suggests that the pathophysiology of DE/AE is multifactorial, including both organic and psychosocial factors. Despite the many publications on this condition, the exact pathogenesis is not yet known. There is currently no single gold standard for diagnosing DE/AE, as operationalized criteria do not exist. The history is the key to the diagnosis. Treatment should be cause-specific. There are many approaches to treatment planning, including various psychological interventions, pharmacotherapy, and specific treatments for infertile men. An approved form of drug therapy does not exist. A number of approaches can be employed for infertile men, including the collection of nocturnal emissions, prostatic massage, prostatic urethra catheterization, penile vibratory stimulation, probe electroejaculation, sperm retrieval by aspiration from either the vas deferens or the epididymis, and testicular sperm extraction.

Keyword

Anejaculation; Delayed ejaculation; Diagnosis; Physiopathology; Therapy

MeSH Terms

Catheterization
Catheters
Diagnosis*
Drug Therapy
Ejaculation*
Epididymis
Humans
Male
Massage
Medical Subject Headings
Psychology
Sperm Retrieval
Spermatozoa
Urethra
Vas Deferens

Figure

  • Fig. 1 Terminology and definitions of delayed ejaculation (DE)/anejaculation (AE) and the related terms.

  • Fig. 2 Relevant aspects of history-taking, physical examination, and investigations.


Cited by  1 articles

Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction
Sun Tae Ahn, Dong Hyun Lee, Hyeong Guk Jeong, Jong Wook Kim, Mi Mi Oh, Hong Seok Park, Du Geon Moon
Investig Clin Urol. 2020;61(1):81-87.    doi: 10.4111/icu.2020.61.1.81.


Reference

1. Munjack DJ, Kanno PH. Retarded ejaculation: a review. Arch Sex Behav. 1979; 8:139–150. PMID: 112949.
Article
2. Shull GR, Sprenkle DH. Retarded ejaculation reconceptualization and implications for treatment. J Sex Marital Ther. 1980; 6:234–246. PMID: 6152867.
Article
3. Segraves RT. Considerations for a better definition of male orgasmic disorder in DSM V. J Sex Med. 2010; 7:690–695. PMID: 20492418.
Article
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association;2013.
5. Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010; 7:1668–1686. PMID: 20388164.
Article
6. Perelman MA. Psychosexual therapy for delayed ejaculation based on the sexual tipping point model. Transl Androl Urol. 2016; 5:563–575. PMID: 27652228.
Article
7. Perelman MA. Reexamining the definitions of PE and DE. J Sex Marital Ther. 2017; 43:633–644. PMID: 27594579.
Article
8. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med. 2005; 2:492–497. PMID: 16422843.
9. Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, et al. Premature ejaculation: an observational study of men and their partners. J Sex Med. 2005; 2:358–367. PMID: 16422867.
10. Waldinger MD, McIntosh J, Schweitzer DH. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. J Sex Med. 2009; 6:2888–2895. PMID: 19627471.
Article
11. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999; 281:537–544. PMID: 10022110.
12. Fugl-Meyer AR, Sjögren Fugl-Meyer K. Sexual disabilities, problems, and satisfaction in 18–74 year old Swedes. Scand J Sexol. 1999; 3:79–105.
13. Simons JS, Carey MP. Prevalence of sexual dysfunctions: results from a decade of research. Arch Sex Behav. 2001; 30:177–219. PMID: 11329727.
14. Perelman MA, Rowland DL. Retarded ejaculation. World J Urol. 2006; 24:645–652. PMID: 17082938.
Article
15. Paduch DA, Polzer P, Morgentaler A, Althof S, Donatucci C, Ni X, et al. Clinical and demographic correlates of ejaculatory dysfunctions other than premature ejaculation: a prospective, observational study. J Sex Med. 2015; 12:2276–2286. PMID: 26511106.
Article
16. Nathan SG. The epidemiology of the DSM-III psychosexual dysfunctions. J Sex Marital Ther. 1986; 12:267–281. PMID: 3493350.
Article
17. Nazareth I, Boynton P, King M. Problems with sexual function in people attending London general practitioners: cross sectional study. BMJ. 2003; 327:423. PMID: 12933729.
Article
18. Blanker MH, Bosch JL, Groeneveld FP, Bohnen AM, Prins A, Thomas S, et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology. 2001; 57:763–768. PMID: 11306400.
Article
19. Corona G, Lee DM, Forti G, O'Connor DB, Maggi M, O'Neill TW, et al. Age-related changes in general and sexual health in middle-aged and older men: results from the European male ageing study (EMAS). J Sex Med. 2010; 7:1362–1380. PMID: 19929914.
Article
20. Rosen RC, Heiman JR, Long JS, Fisher WA, Sand MS. Men with sexual problems and their partners: findings from the international survey of relationships. Arch Sex Behav. 2016; 45:159–173. PMID: 26228991.
Article
21. Perelman MA. Patient highlights. Delayed ejaculation. J Sex Med. 2013; 10:1189–1190. PMID: 23551543.
22. Butcher MJ, Welliver RC Jr, Sadowski D, Botchway A, Köhler TS. How is delayed ejaculation defined and treated in North America? Andrology. 2015; 3:626–631. PMID: 26013106.
Article
23. Althof SE. Psychological interventions for delayed ejaculation/orgasm. Int J Impot Res. 2012; 24:131–136. PMID: 22378496.
Article
24. Masters WH, Johnson VE. Human sexual inadequacy. Boston: Little, Brown;1970.
25. Bancroft J. Human sexuality and its problem. London: Churchill Livingstone;2008.
26. Rowland DL, Keeney C, Slob AK. Sexual response in men with inhibited or retarded ejaculation. Int J Impot Res. 2004; 16:270–274. PMID: 14961061.
Article
27. Teloken P, Nelson C, Mulhall J. Secondary delayed orgasm: patterns, correlates and predictors. J Urol. 2012; 187:e562.
28. Xia JD, Han YF, Pan F, Zhou LH, Chen Y, Dai YT. Clinical characteristics and penile afferent neuronal function in patients with primary delayed ejaculation. Andrology. 2013; 1:787–792. PMID: 23970455.
Article
29. Nelson CJ, Ahmed A, Valenzuela R, Parker M, Mulhall JP. Assessment of penile vibratory stimulation as a management strategy in men with secondary retarded orgasm. Urology. 2007; 69:552–555. discussion 555-6. PMID: 17382163.
Article
30. Perelman MA. Idiosyncratic masturbation patterns: a key unexplored variable in the treatment of retarded ejaculation by the practicing urologist. J Urol. 2005; 173:340. PMID: 15643170.
31. Apfelbaum B. Retarded ejaculation: a much-misunderstood syndrome. In : Lieblum SR, Rosen RC, editors. Principles and practice of sex therapy. 2nd ed. New York: Guilford Press;1989. p. 168–202.
32. Apfelbaum B. Retarded ejaculation: a much-misunderstood syndrome. In : Leiblum SR, Rosen RC, editors. Principles and practice of sex therapy. 3rd ed. New York: Guilford Press;2000. p. 205–241.
33. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol. 1994; 151:54–61. PMID: 8254833.
Article
34. O'Leary MP, Rhodes T, Girman CJ, Jacobson DJ, Roberts RO, Lieber MM, et al. Distribution of the brief male sexual inventory in community men. Int J Impot Res. 2003; 15:185–191. PMID: 12904804.
35. Corona G, Jannini EA, Lotti F, Boddi V, De Vita G, Forti G, et al. Premature and delayed ejaculation: two ends of a single continuum influenced by hormonal milieu. Int J Androl. 2011; 34:41–48. PMID: 20345874.
Article
36. Edwards AE, Husted JR. Penile sensitivity, age, and sexual behavior. J Clin Psychol. 1976; 32:697–700. PMID: 956441.
Article
37. Halata Z, Munger BL. The neuroanatomical basis for the protopathic sensibility of the human glans penis. Brain Res. 1986; 371:205–230. PMID: 3697758.
Article
38. Tammaro A, Parisella FR, Cavallotti C, Persechino S, Cavallotti C. Ultrastructural age-related changes in the sensory corpuscles of the human genital skin. J Biol Regul Homeost Agents. 2013; 27:241–245. PMID: 23489703.
39. Rowland DL, Greenleaf W, Mas M, Myers L, Davidson JM. Penile and finger sensory thresholds in young, aging, and diabetic males. Arch Sex Behav. 1989; 18:1–12. PMID: 2712681.
Article
40. Rowland DL. Penile sensitivity in men: a composite of recent findings. Urology. 1998; 52:1101–1105. PMID: 9836563.
Article
41. Montejo AL, Montejo L, Navarro-Cremades F. Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psychiatry. 2015; 28:418–423. PMID: 26382168.
Article
42. Hendren SK, O'Connor BI, Liu M, Asano T, Cohen Z, Swallow CJ, et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg. 2005; 242:212–223. PMID: 16041212.
Article
43. Brindley GS, Gillan P. Men and women who do not have orgasms. Br J Psychiatry. 1982; 140:351–356. PMID: 7093610.
Article
44. Richardson D, Nalabanda A, Goldmeier D. Retarded ejaculation: a review. Int J STD AIDS. 2006; 17:143–150. PMID: 16509998.
45. Foley S. The complex etiology of delayed ejaculation: assessment and treatment implications. J Fam Psychother. 2009; 20:261–282.
Article
46. Jern P, Santtila P, Witting K, Alanko K, Harlaar N, Johansson A, et al. Premature and delayed ejaculation: genetic and environmental effects in a population-based sample of Finnish twins. J Sex Med. 2007; 4:1739–1749. PMID: 17888070.
Article
47. Jern P, Westberg L, Johansson A, Gunst A, Eriksson E, Sandnabba K, et al. A study of possible associations between single nucleotide polymorphisms in the serotonin receptor 1A, 1B, and 2C genes and self-reported ejaculation latency time. J Sex Med. 2012; 9:866–872. PMID: 22240001.
Article
48. Jern P, Westberg L, Johansson A, Jonsson L, Corander J, Sandnabba NK, et al. Are single nucleotide polymorphisms in the oxytocin and vasopressin 1A/1B receptor genes likely candidates for variation in ejaculatory function? BJU Int. 2012; 110:E1173–E1180. PMID: 22882465.
Article
49. Corona G, Ricca V, Bandini E, Mannucci E, Lotti F, Boddi V, et al. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med. 2009; 6:1259–1269. PMID: 19473282.
50. Stevenson JM, Bishop JR. Genetic determinants of selective serotonin reuptake inhibitor related sexual dysfunction. Pharmacogenomics. 2014; 15:1791–1806. PMID: 25493571.
Article
51. Zourková A, Hadasová E. Relationship between CYP 2D6 metabolic status and sexual dysfunction in paroxetine treatment. J Sex Marital Ther. 2002; 28:451–461. PMID: 12378847.
52. Bishop JR, Moline J, Ellingrod VL, Schultz SK, Clayton AH. Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology. 2006; 31:2281–2288. PMID: 16710319.
Article
53. Zourková A, Cesková E, Hadasová E, Ravcuková B. Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity. J Sex Marital Ther. 2007; 33:343–355. PMID: 17541852.
54. Perlis RH, Laje G, Smoller JW, Fava M, Rush AJ, McMahon FJ. Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. Neuropsychopharmacology. 2009; 34:1819–1828. PMID: 19295509.
Article
55. Strohmaier J, Wüst S, Uher R, Henigsberg N, Mors O, Hauser J, et al. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. World J Biol Psychiatry. 2011; 12:528–538. PMID: 21388237.
56. Liang CS, Ho PS, Chiang KT, Su HC. 5-HT2A receptor -1438 G/A polymorphism and serotonergic antidepressant-induced sexual dysfunction in male patients with major depressive disorder: a prospective exploratory study. J Sex Med. 2012; 9:2009–2016. PMID: 22612784.
Article
57. de Klerk OL, Nolte IM, Bet PM, Bosker FJ, Snieder H, den Boer JA, et al. ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder. Pharmacogenomics J. 2013; 13:349–353. PMID: 22641028.
Article
58. Clark SL, Adkins DE, Aberg K, Hettema JM, McClay JL, Souza RP, et al. Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D. Psychol Med. 2012; 42:1151–1162. PMID: 22041458.
Article
59. Kurose K, Hiratsuka K, Ishiwata K, Nishikawa J, Nonen S, Azuma J, et al. Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression. Psychiatry Res. 2012; 198:424–429. PMID: 22445761.
Article
60. Adkins DE, Clark SL, Åberg K, Hettema JM, Bukszár J, McClay JL, et al. Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D. Transl Psychiatry. 2012; 2:e129. PMID: 22760553.
Article
61. Huang YY, Zhang XS, Gao JJ, Gao P, Liang CZ. Association between serotonin transporter 5-HTTLPR and STin2 VNTR polymorphisms and anejaculation: a preliminary report. Asian J Androl. 2017; 19:719–720. PMID: 27586024.
Article
62. Waldinger MD, Berendsen HH, Blok BF, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res. 1998; 92:111–118. PMID: 9638953.
Article
63. Waldinger MD, Schweitzer DH. Retarded ejaculation in men: an overview of psychological and neurobiological insights. World J Urol. 2005; 23:76–81. PMID: 15937707.
Article
64. McMahon CG. Premature ejaculation. Indian J Urol. 2007; 23:97–108. PMID: 19675782.
Article
65. Moretti M, Facchini F, Grande M, Larosa M, Leone M, Ziglioli F, et al. Ejaculatory system cysts: a case report. Urologia. 2014; 81(Suppl 23):S32–S37. PMID: 24665031.
Article
66. Taskinen S, Heikkilä J, Santtila P, Rintala R. Posterior urethral valves and adult sexual function. BJU Int. 2012; 110:E392–E396. PMID: 22448709.
Article
67. Reddy SS, Inouye BM, Anele UA, Abdelwahab M, Le B, Gearhart JP, et al. Sexual health outcomes in adults with complete male epispadias. J Urol. 2015; 194:1091–1095. PMID: 25916676.
Article
68. Park W, Zwink N, Rösch WH, Schmiedeke E, Stein R, Schmidt D, et al. Sexual function in adult patients with classic bladder exstrophy: a multicenter study. J Pediatr Urol. 2015; 11:125.e1–125.e6. PMID: 25986209.
Article
69. Frey A, Pedersen C, Lindberg H, Bisbjerg R, Sønksen J, Fode M. Prevalence and predicting factors for commonly neglected sexual side effects to external-beam radiation therapy for prostate cancer. J Sex Med. 2017; 14:558–565. PMID: 28258954.
Article
70. Sullivan JF, Stember DS, Deveci S, Akin-Olugbade Y, Mulhall JP. Ejaculation profiles of men following radiation therapy for prostate cancer. J Sex Med. 2013; 10:1410–1416. PMID: 23433425.
Article
71. Lew-Starowicz M, Rola R. Sexual dysfunctions and sexual quality of life in men with multiple sclerosis. J Sex Med. 2014; 11:1294–1301. PMID: 24612517.
72. Anderson KD, Borisoff JF, Johnson RD, Stiens SA, Elliott SL. Long-term effects of spinal cord injury on sexual function in men: implications for neuroplasticity. Spinal Cord. 2007; 45:338–348. PMID: 17016492.
Article
73. Lindau ST, Tang H, Gomero A, Vable A, Huang ES, Drum ML, et al. Sexuality among middle-aged and older adults with diagnosed and undiagnosed diabetes: a national, population-based study. Diabetes Care. 2010; 33:2202–2210. PMID: 20802158.
74. Ohl DA, Quallich SA, Sønksen J, Brackett NL, Lynne CM. Anejaculation and retrograde ejaculation. Urol Clin North Am. 2008; 35:211–220. PMID: 18423241.
Article
75. Chen J. The pathophysiology of delayed ejaculation. Transl Androl Urol. 2016; 5:549–562. PMID: 27652227.
Article
76. Corona G, Jannini EA, Mannucci E, Fisher AD, Lotti F, Petrone L, et al. Different testosterone levels are associated with ejaculatory dysfunction. J Sex Med. 2008; 5:1991–1998. PMID: 18399946.
Article
77. Morgentaler A, Polzer P, Althof S, Bolyakov A, Donatucci C, Ni X, et al. Delayed ejaculation and associated complaints: relationship to ejaculation times and serum testosterone levels. J Sex Med. 2017; 14:1116–1124. PMID: 28807505.
Article
78. Nair S, Milsom S. Anejaculation as the presenting feature of pituitary microadenoma. Fertil Steril. 2008; 90:2012.e21–2012.e23.
Article
79. Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005; 90:6472–6479. PMID: 16204360.
Article
80. La Torre A, Giupponi G, Duffy D, Conca A, Cai T, Scardigli A. Sexual dysfunction related to drugs: a critical review. part V: α-blocker and 5-ARI drugs. Pharmacopsychiatry. 2016; 49:3–13. PMID: 26569417.
Article
81. Abdel-Hamid IA, Saleh el-S. Primary lifelong delayed ejaculation: characteristics and response to bupropion. J Sex Med. 2011; 8:1772–1779. PMID: 21114770.
Article
82. Tsimtsiou Z, Hatzimouratidis K, Nakopoulou E, Kyrana E, Salpigidis G, Hatzichristou D. Predictors of physicians' involvement in addressing sexual health issues. J Sex Med. 2006; 3:583–588. PMID: 16839313.
83. Courtois F, Charvier K, Leriche A, Vézina JG, Côté I, Raymond D, et al. Perceived physiological and orgasmic sensations at ejaculation in spinal cord injured men. J Sex Med. 2008; 5:2419–2430. PMID: 18466272.
Article
84. Paduch DA, Polzer PK, Ni X, Basaria S. Testosterone replacement in androgen-deficient men with ejaculatory dysfunction: a randomized controlled trial. J Clin Endocrinol Metab. 2015; 100:2956–2962. PMID: 26158605.
Article
85. Maggi M, Heiselman D, Knorr J, Iyengar S, Paduch DA, Donatucci CF. Impact of testosterone solution 2% on ejaculatory dysfunction in hypogonadal men. J Sex Med. 2016; 13:1220–1226. PMID: 27436077.
Article
86. Masui H, Ike H, Yamaguchi S, Oki S, Shimada H. Male sexual function after autonomic nerve-preserving operation for rectal cancer. Dis Colon Rectum. 1996; 39:1140–1145. PMID: 8831531.
Article
87. Pettus JA, Carver BS, Masterson T, Stasi J, Sheinfeld J. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer. Urology. 2009; 73:328–331. discussion 331-2. PMID: 19022490.
Article
88. Meng X, Fan L, Liu J, Wang T, Yang J, Wang J, et al. Fresh semen quality in ejaculates produced by nocturnal emission in men with idiopathic anejaculation. Fertil Steril. 2013; 100:1248–1252. PMID: 23987518.
Article
89. Soeterik TF, Veenboer PW, Lock TM. Electroejaculation in psychogenic anejaculation. Fertil Steril. 2014; 101:1604–1608. PMID: 24726223.
Article
90. Perelman MA. Sex coaching for physicians: combination treatment for patient and partner. Int J Impot Res. 2003; 15(Suppl 5):S67–S74. PMID: 14551580.
Article
91. Abdel-Hamid IA, Elsaied MA, Mostafa T. The drug treatment of delayed ejaculation. Transl Androl Urol. 2016; 5:576–591. PMID: 27652229.
Article
92. Lyons MD, Lentz AC, Coward RM. Lisdexamfetamine dimesylate (Vyvanse) for the treatment of neurogenic anejaculation. Am J Mens Health. 2017; 11:618–619. PMID: 27402622.
Article
93. Pryor JP. Erectile and ejaculatory problems in infertility. In : Hargreave TB, editor. Male infertility. London: Springer;1997. p. 319–336.
94. Leduc BE, Fournier C, Jacquemin G, Lepage Y, Vinet B, Hétu PO, et al. Midodrine in patients with spinal cord injury and anejaculation: a double-blind randomized placebo-controlled pilot study. J Spinal Cord Med. 2015; 38:57–62. PMID: 24969635.
Article
95. Fahmy I, Kamal A, Metwali M, Rhodes C, Mansour R, Serour G, et al. Vigorous prostatic massage: a simple method to retrieve spermatozoa for intracytoplasmic sperm injection in psychogenic anejaculation: case report. Hum Reprod. 1999; 14:2050–2053. PMID: 10438425.
96. Soler JM, Previnaire JG, Mieusset R. Evidence of a new pattern of ejaculation in men with spinal cord injury: ejaculation dyssynergia and implications for fertility. Spinal Cord. 2016; 54:1210–1214. PMID: 27324318.
Article
97. Castle SM, Jenkins LC, Ibrahim E, Aballa TC, Lynne CM, Brackett NL. Safety and efficacy of a new device for inducing ejaculation in men with spinal cord injuries. Spinal Cord. 2014; 52(Suppl 2):S27–S29. PMID: 25082380.
Article
98. Fode M, Ohl DA, Sønksen J. A step-wise approach to sperm retrieval in men with neurogenic anejaculation. Nat Rev Urol. 2015; 12:607–616. PMID: 26481575.
Article
99. Raviv G, Madgar I, Elizur S, Zeilig G, Levron J. Testicular sperm retrieval and intra cytoplasmic sperm injection provide favorable outcome in spinal cord injury patients, failing conservative reproductive treatment. Spinal Cord. 2013; 51:642–644. PMID: 23689394.
Article
Full Text Links
  • WJMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr